Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in Western China

被引:16
|
作者
Hu, Ying [1 ]
Zhong, Xiao-ni [1 ]
Peng, Bin [1 ]
Zhang, Yan [1 ]
Liang, Hao [2 ]
Dai, Jiang-hong [3 ]
Zhang, Ju-ying [4 ]
Huang, Ai-long [5 ]
机构
[1] Chongqing Med Univ, Sch Publ Hlth & Management, Dept Hlth Stat & Informat Management, Chongqing, Peoples R China
[2] Guangxi Med Univ, Sch Publ Hlth, Dept Epidemiol & Med Stat, Nanning, Peoples R China
[3] Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Xinjiang, Peoples R China
[4] Sichuan Univ, Sch Publ Hlth, Dept Epidemiol & Med Stat, Chengdu, Sichuan, Peoples R China
[5] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China
来源
BMC INFECTIOUS DISEASES | 2018年 / 18卷
关键词
Pre-exposure prophylaxis; PrEP; MSM; Adherence; Barriers and benefits; TRANSGENDER WOMEN; DOUBLE-BLIND; YOUNG MEN; INFECTION; PREVENTION; TRIAL; PREP; WILLINGNESS; TENOFOVIR; EFFICACY;
D O I
10.1186/s12879-018-3497-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: To investigate the associations between the perceived barriers and benefits of using HIV pre-exposure prophylaxis medication, including worries about the side effects, disliking taking drugs, perceived burden of taking medication, positive expectations as to the efficacy of the drugs, favourable doctor-patient relationships, and medication adherence among men who have sex with men (MSM) to provide a target for improving medication adherence and reducing HIV infection among MSM. Methods: MSM were recruited in western China from April 2013 to October 2014, administered oral tenofovir (TDF) daily and followed up every 12weeks for 2years. At each follow-up, the medication rate was calculated based on the self-reported number of missed doses over 2weeks, and then, the medication adherence was evaluated. The barriers and benefits perceived during medication were obtained by a self-administered questionnaire, and their effects on medication adherence were analysed by linear mixed models. Results: A total of 411 participants were enrolled in this study, and 1561 follow-up observation points were obtained. The average medication rate was 0.620.37, and the medication rate increased with longer follow-up (P<0.05). The medication rate was higher among MSM who were divorced (compared to those who were unmarried, P<0.0001). MSM with more positive expectations as to the efficacy of the drugs showed higher rates of medication (P<0.0001), while those who were more worried about side effects had a lower medication rate (P=0.0208). In contrast, the dislike of taking the drugs and the burden perceived during medication had no effects on the actual medication rate of taking TDF (P>0.05). Conclusion: How to obtain and maintain high medication adherence among MSM is the key to the PrEP intervention strategy for effective reduction of HIV infection. For MSM in China, we should deepen their understanding of the effectiveness and safety of PrEP and increase their confidence in PrEP, thereby improving their medication adherence.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Awareness and Acceptability of Pre-exposure HIV Prophylaxis Among Men Who have Sex with Men in Baltimore
    Susan A. Fallon
    Ju Nyeong Park
    Christine Powell Ogbue
    Colin Flynn
    Danielle German
    AIDS and Behavior, 2017, 21 : 1268 - 1277
  • [42] The Impact of Alcohol and Illicit Drug use on Adherence to HIV Pre-exposure Prophylaxis among Men who have Sex with Men
    Paula De Franca, Francisco Alisson
    de Barros Silva, Paulo Goberlanio
    de Franca Fonteles, Marta Maria
    JOURNAL OF YOUNG PHARMACISTS, 2021, 13 (03) : 251 - 256
  • [43] Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP)
    Wang, Hongyi
    Zhang, Yonghui
    Mei, Zhu
    Jia, Yueru
    Leuba, Sequoia I.
    Zhang, Jing
    Chu, Zhenxing
    Ding, Haibo
    Jiang, Yongjun
    Geng, Wenqing
    Shang, Hong
    Xu, Junjie
    BMC INFECTIOUS DISEASES, 2019, 19 (01)
  • [44] Loss to Follow-Up from HIV Pre-Exposure Prophylaxis Care in Men Who Have Sex with Men in West Africa
    Eubanks, August
    Coulibaly, Bakary
    Keita, Bintou
    Anoma, Camille
    Dah, Ter
    Mensah, Ephrem
    Maradan, Gwenaelle
    Bourrelly, Michel
    Mora, Marion
    Riegel, Lucas
    Castro, Daniela Rojas
    Yaya, Issifou
    Spire, Bruno
    Laurent, Christian
    Sagaon-Teyssier, Luis
    VIRUSES-BASEL, 2022, 14 (11):
  • [45] Willingness to use pre-exposure prophylaxis among Black and White men who have sex with men in Atlanta, Georgia
    Rolle, Charlotte-Paige
    Rosenberg, Eli S.
    Luisi, Nicole
    Grey, Jeremy
    Sanchez, Travis
    del Rio, Carlos
    Peterson, John L.
    Frew, Paula M.
    Sullivan, Patrick S.
    Kelley, Colleen F.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2017, 28 (09) : 849 - 857
  • [46] Oral Pre-exposure Prophylaxis Uptake and Acceptability Among Men Who Have Sex With Men: A Scoping Review of the Literature
    Moyo, Perez Livias
    Nunu, Wilfred Njabulo
    AMERICAN JOURNAL OF MENS HEALTH, 2023, 17 (05)
  • [47] Factors Associated With Sex-Related Pre-exposure Prophylaxis Adherence Among Men Who Have Sex With Men in New York City in HPTN 067
    Mannheimer, Sharon
    Hirsch-Moverman, Yael
    Franks, Julie
    Loquere, Avelino
    Hughes, James P.
    Li, Maoji
    Amico, K. Rivet
    Grant, Robert M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 80 (05) : 551 - 558
  • [48] Perceived Likelihood of Using HIV Pre-exposure Prophylaxis Medications Among Young Men Who Have Sex with Men
    Brian Mustanski
    Amy K. Johnson
    Robert Garofalo
    Daniel Ryan
    Michelle Birkett
    AIDS and Behavior, 2013, 17 : 2173 - 2179
  • [49] Perceived Likelihood of Using HIV Pre-exposure Prophylaxis Medications Among Young Men Who Have Sex with Men
    Mustanski, Brian
    Johnson, Amy K.
    Garofalo, Robert
    Ryan, Daniel
    Birkett, Michelle
    AIDS AND BEHAVIOR, 2013, 17 (06) : 2173 - 2179
  • [50] Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)
    Mayer, Kenneth H.
    Yuhas, Krista
    Amico, K. Rivet
    Wilkin, Timothy
    Landovitz, Raphael J.
    Richardson, Paul
    Marzinke, Mark A.
    Eshleman, Susan H.
    Cottle, Leslie M.
    Marcus, Cheryl
    Chege, Wairimu
    Rinehart, Alex R.
    Rooney, James F.
    Andrew, Philip
    Salata, Robert A.
    Magnus, Manya
    Farley, Jason E.
    Liu, Albert Y.
    Frank, Ian
    Ho, Ken
    Santana, Jorge
    Stekler, Joanne D.
    Chen, Ying Q.
    McCauley, Marybeth
    Gulick, Roy M.
    AIDS AND BEHAVIOR, 2022, 26 (12) : 4107 - 4114